• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

佩罗尼氏病成纤维细胞在严重联合免疫缺陷(SCID)小鼠模型中表现出致瘤性。

Peyronie's disease fibroblasts demonstrate tumorigenicity in the severe combined immunodeficient (SCID) mouse model.

作者信息

Mulhall J P, Martin D J, Lubrano T, Moser M, Kwon E, Wojcik E, Shankey T V

机构信息

Andrology Research Laboratory, Hines, Illinois, USA.

出版信息

Int J Impot Res. 2004 Apr;16(2):99-104. doi: 10.1038/sj.ijir.3901183.

DOI:10.1038/sj.ijir.3901183
PMID:14973530
Abstract

Peyronie's disease is a localized connective tissue disorder, caused by trauma to the erect penis, which results in cellular proliferation and excess extracellular matrix production within the tunica albuginea of the penis. We have previously demonstrated that cells derived from Peyronie's disease plaque tissue demonstrate increased cell growth, increased S-phase on flow cytometry, stabilization and inactivation of p53, and consistent morphologic transformation, all suggesting that these cells are biologically transformed. Severe combined immunodeficient (SCID) mice have been used extensively to study the pathobiology of malignant and benign tissue and cells. This study was undertaken to determine if Peyronie's derived fibroblasts had the potential to demonstrate tumorigenicity in the SCID mouse model, thus confirming their biologically transformed nature. Cultured fibroblasts were derived from three sources, namely, plaque tissue excised from men with Peyronie's disease, tunical tissue excised from young men with congenital penile curvature and neonatal foreskins. BALB/C SCID mice were divided into three groups and each group was inoculated with cultured fibroblasts from each of the three different sources. All animals were evaluated regularly and maintained in isolation for a period of 3 months following inoculation. All SCID mice inoculated with cells derived from Peyronie's disease plaque tissue (n=10) developed subcutaneous nodules at a mean time period of 2.5+/-0.5 months following injection. The mean maximum dimension and weight of the nodules at the time of killing the animal was 1.1+/-0.2 cms and 0.6+/-0.2 g, respectively. Histologically, the nodules were composed of large pleomorphic epithelioid cells with a high mitotic activity, which were negative for cytokeratin but positive for vimentin. None of the SCID mice inoculated with cells cultured from either normal tunica (n=5) or foreskin (n=5) developed subcutaneous nodules. In conclusion, the tumorigenic nature of Peyronie's disease plaque-derived fibroblasts sheds further light on the pathobiologic characteristics of these cells. Specifically, these data confirm that cells cultured from Peyronie's disease plaque are biologically transformed. Future refinement and study of this animal model may permit a more complete understanding of the pathophysiology of Peyronie's disease and fibromatoses in general. Furthermore, such an animal model may, in the future, allow a more ready evaluation of the therapeutic interventions for Peyronie's disease.

摘要

佩罗尼氏病是一种局限性结缔组织疾病,由勃起阴茎受到创伤引起,导致阴茎白膜内细胞增殖和细胞外基质过度产生。我们之前已经证明,源自佩罗尼氏病斑块组织的细胞表现出细胞生长增加、流式细胞术检测S期增加、p53稳定和失活以及一致的形态学转变,所有这些都表明这些细胞发生了生物学转化。严重联合免疫缺陷(SCID)小鼠已被广泛用于研究恶性和良性组织及细胞的病理生物学。本研究旨在确定源自佩罗尼氏病的成纤维细胞在SCID小鼠模型中是否具有致瘤潜力,从而证实其生物学转化的性质。培养的成纤维细胞来自三个来源,即从患有佩罗尼氏病的男性切除的斑块组织、从患有先天性阴茎弯曲的年轻男性切除的白膜组织以及新生儿包皮。将BALB/C SCID小鼠分为三组,每组接种来自三种不同来源的培养成纤维细胞。定期对所有动物进行评估,并在接种后隔离饲养3个月。所有接种源自佩罗尼氏病斑块组织细胞的SCID小鼠(n = 10)在注射后平均2.5±0.5个月出现皮下结节。处死动物时,结节的平均最大尺寸和重量分别为1.1±0.2厘米和0.6±0.2克。组织学上,结节由具有高有丝分裂活性的大的多形性上皮样细胞组成,细胞角蛋白阴性但波形蛋白阳性。接种从正常白膜(n = 5)或包皮(n = 5)培养的细胞的SCID小鼠均未出现皮下结节。总之,佩罗尼氏病斑块来源的成纤维细胞的致瘤性质进一步揭示了这些细胞的病理生物学特征。具体而言,这些数据证实从佩罗尼氏病斑块培养的细胞发生了生物学转化。对该动物模型未来的改进和研究可能有助于更全面地了解佩罗尼氏病和一般纤维瘤病的病理生理学。此外,这样的动物模型未来可能会使对佩罗尼氏病治疗干预措施的评估更加容易。

相似文献

1
Peyronie's disease fibroblasts demonstrate tumorigenicity in the severe combined immunodeficient (SCID) mouse model.佩罗尼氏病成纤维细胞在严重联合免疫缺陷(SCID)小鼠模型中表现出致瘤性。
Int J Impot Res. 2004 Apr;16(2):99-104. doi: 10.1038/sj.ijir.3901183.
2
Chromosomal instability is demonstrated by fibroblasts derived from the tunica of men with Peyronie's disease.佩罗尼氏病男性白膜来源的成纤维细胞表现出染色体不稳定。
Int J Impot Res. 2004 Jun;16(3):288-93. doi: 10.1038/sj.ijir.3901170.
3
Perturbation of cell cycle regulators in Peyronie's disease.佩罗尼氏病中细胞周期调节因子的扰动。
Int J Impot Res. 2001 Dec;13 Suppl 5:S21-8. doi: 10.1038/sj.ijir.3900771.
4
Peyronie's disease cell culture models: phenotypic, genotypic and functional analyses.佩罗尼氏病细胞培养模型:表型、基因型和功能分析。
Int J Impot Res. 2002 Oct;14(5):397-405. doi: 10.1038/sj.ijir.3900874.
5
Basic fibroblast growth factor expression in Peyronie's disease.佩罗尼氏病中碱性成纤维细胞生长因子的表达
J Urol. 2001 Feb;165(2):419-23. doi: 10.1097/00005392-200102000-00016.
6
Radiation increases fibrogenic cytokine expression by Peyronie's disease fibroblasts.辐射会增加佩罗尼氏病成纤维细胞的促纤维化细胞因子表达。
J Urol. 2003 Jul;170(1):281-4. doi: 10.1097/01.ju.0000070860.78370.08.
7
Comparison of apoptotic gene expression profiles between Peyronie's disease plaque and tunica albuginea.比较阴茎硬结症斑块与白膜之间凋亡基因表达谱。
Adv Clin Exp Med. 2012 Sep-Oct;21(5):607-14.
8
Inhibition of Peyronie's plaque fibroblast proliferation by biologic agents.
Int J Impot Res. 2000 Sep;12 Suppl 3:S25-31. doi: 10.1038/sj.ijir.3900558.
9
Microstructural disorders of tunica albuginea in patients affected by Peyronie's disease with or without erection dysfunction.患有或未患有勃起功能障碍的佩罗尼氏病患者白膜的微观结构紊乱。
J Urol. 1993 Dec;150(6):1806-9. doi: 10.1016/s0022-5347(17)35901-3.
10
Reduction in Peyronie's-like plaque size using a vacuum erection device in a rat model of Peyronie's disease via the TGF-β/SMAD signalling pathway.在佩罗尼氏病大鼠模型中,通过转化生长因子-β/信号转导和转录激活因子信号通路,利用真空勃起装置减小佩罗尼氏样斑块大小。
Andrologia. 2018 Sep;50(7):e13051. doi: 10.1111/and.13051. Epub 2018 May 28.

引用本文的文献

1
Peyronie's disease: is it genetic or not?佩罗尼氏病:它有遗传性吗?
Transl Androl Urol. 2020 Mar;9(Suppl 2):S262-S268. doi: 10.21037/tau.2019.10.21.
2
Increased Risk of Cancer in Men With Peyronie's Disease: A Cohort Study Using a Large United States Insurance Claims Database.佩罗尼氏病男性患癌风险增加:一项使用美国大型保险理赔数据库的队列研究。
Sex Med. 2019 Dec;7(4):403-408. doi: 10.1016/j.esxm.2019.08.007. Epub 2019 Sep 14.
3
The Genetic Basis of Peyronie Disease: A Review.《佩罗尼病的遗传学基础:综述》。
Sex Med Rev. 2016 Jan;4(1):85-94. doi: 10.1016/j.sxmr.2015.10.002. Epub 2016 Jan 8.
4
PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.佩罗尼氏病:病因、诊断与治疗综述
Curr Sex Health Rep. 2015 Jun 1;7(2):117-131. doi: 10.1007/s11930-015-0045-y.
5
The transcriptional signatures of cells from the human Peyronie's disease plaque and the ability of these cells to generate a plaque in a rat model suggest potential therapeutic targets.来自人类佩罗尼氏病斑块的细胞转录特征以及这些细胞在大鼠模型中形成斑块的能力提示了潜在的治疗靶点。
J Sex Med. 2015 Feb;12(2):313-27. doi: 10.1111/jsm.12760. Epub 2014 Dec 11.
6
Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.采用 PDE5 抑制剂治疗 Peyronie 病:一种抗纤维化策略。
Nat Rev Urol. 2010 Apr;7(4):215-21. doi: 10.1038/nrurol.2010.24. Epub 2010 Mar 9.